In Vitro Maturation of Immature Oocytes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome Ovarian Hyperstimulation Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Repeated IVF Failure S/P Hyperstimulation PCOS Fertility Preservation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In Vitro Maturation of immature oocytes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with PCOS
* Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
* Women diagnosed with cancer who are interested in fertility preservation
* Women with repeated IVF failure

Exclusion Criteria

* Severe cases of endometriosis
* Large myomas
* Hydrosalpinxs Technical problem with previous oocytes pick-up

Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ariel Hourvitz

Role: PRINCIPAL_INVESTIGATOR

IVF Unit, Sheba Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IVF Unit, Shea Medical Center, Tel-Hashomer

Ramat Gan, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-06-4317-AH-CTIL

Identifier Type: -

Identifier Source: org_study_id